Alembic Ltd
Company Profile
Business description
Alembic Ltd is engaged in the Active Pharmaceutical Ingredient (API) and Real Estate businesses. The Active Pharmaceutical Ingredient (API) business includes the manufacturing and marketing of fermentation and chemistry-based Active Pharmaceutical Ingredients (API) and Research and Development activities at Vadodara. The Real Estate business includes the construction of residential and commercial real estate projects, project management and marketing consultancy, and leasing of commercial properties to various tenants. The Company operates through two reportable segments: Active Pharmaceutical Ingredient (API) and Real Estate, with Active Pharmaceutical Ingredient (API) generating the maximum revenue.
Contact
Alembic Road
VadodaraGJ390 003
INDT: +91 2656637000
Sector
Real Estate
Stock type
Cyclical
Industry
Real Estate - Development
Fiscal Year End
31 March 2027
Employees
329
Stocks News & Analysis
stocks
Lithium’s latest drop and what it means for ASX investors
stocks
Major ASX miner remains overvalued following production update
stocks
Ahead of earnings, is Alphabet stock a buy, a sell, or fairly valued?
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,976.90 | 33.40 | 0.37% |
| CAC 40 | 8,349.80 | 9.69 | 0.12% |
| DAX 40 | 24,971.30 | 124.61 | 0.50% |
| Dow JONES (US) | 52,185.65 | 346.39 | 0.67% |
| FTSE 100 | 10,572.24 | 47.48 | 0.45% |
| HKSE | 25,132.29 | 10.76 | -0.04% |
| NASDAQ | 25,824.70 | 316.63 | 1.24% |
| Nikkei 225 | 66,232.19 | 2,091.07 | 3.26% |
| NZX 50 Index | 13,656.03 | 40.00 | -0.29% |
| S&P 500 | 7,499.35 | 56.07 | 0.75% |
| S&P/ASX 200 | 8,793.30 | 36.30 | 0.41% |
| SSE Composite Index | 3,864.37 | 68.09 | 1.79% |